About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Japan’s Ministry of Health, Labor and Welfare said the week to Oct 4 (2026 Week 40) saw 42,320 influenza cases reported by sentinel medical nationwide institutions, about 1.6x the prior week and roughly 7.3x year-ago. Average cases per sentinel site

2026-10-09

Japan’s Ministry of Health, Labor and Welfare said the week to Oct 4 (2026 Week 40) saw 42,320 influenza cases reported by sentinel medical nationwide institutions, about 1.6x the prior week and roughly 7.3x year-ago. Average cases per sentinel site were 11.35. National influenza activity reached the advisory level for the first time this season.

Other News
2026-10-09

According to sources close to BASF, the current offer for Evonik is not expected to be final.

According to sources close to BASF, the current offer for Evonik is not expected to be final.
2026-10-09

Wohua Pharmaceutical said its 2026 first-nine-months revenue fell 5.73% YoY to 589 mln yuan. Net profit rose 44.78% YoY to 92.65 mln yuan; adjusted net profit (ex-items) rose 47.94% YoY to 90.65 mln yuan. Net cash from operating activities increased

Wohua Pharmaceutical said its 2026 first-nine-months revenue fell 5.73% YoY to 589 mln yuan. Net profit rose 44.78% YoY to 92.65 mln yuan; adjusted net profit (ex-items) rose 47.94% YoY to 90.65 mln yuan. Net cash from operating activities increased 11.63% YoY to 121 mln yuan. In Q3 2026, revenue dipped 1.89% YoY to 195 mln yuan, net profit rose 29.87% YoY to 25.09 mln yuan and adjusted net profit rose 33.19% YoY to 24.69 mln yuan.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.